No Data
No Data
No Data
No Data
No Data
Nomura Adjusts Autek China's Price Target to 19.96 Yuan From 22.16 Yuan, Keeps at Neutral
03:43 AM EDT, 04/29/2024 (MT Newswires) -- Nomura Adjusts Autek China's Price Target to 19.96 Yuan From 22.16 Yuan, Keeps at Neutral Price (RMB): ¥19.14, Change: ¥+1.08, Percent Change: +5.98%
MT NewswiresApr 29 03:43 ET
Opcom TV (300595.SZ) announced first-quarter results, net profit of 193 million yuan, up 11.39% year on year
Opcom TV (300595.SZ) released its report for the first quarter of 2024, and the company achieved revenue during the reporting period...
Zhitong FinanceApr 26 05:11 ET
Opcon TV (300595.SZ): The production cost of self-produced materials is significantly lower than outsourced, which can effectively reduce the manufacturing cost of lenses
Gelonghui, April 16 | Opcon TV (300595.SZ) said on the investor interactive platform that the proportion of self-produced materials used is gradually increasing and is changing; the ultra-high permeable corneal shaping lens materials that have already been submitted for registration are self-produced. The production cost of self-produced materials is significantly lower than outsourced, which can effectively reduce the manufacturing cost of lenses.
Gelonghui FinanceApr 16 06:25 ET
Opcom TV (300595.SZ): As of April 10, 2024, the total number of shareholders of the company was 71,950
Gelonghui, April 12 | Opcon TV (300595.SZ) said on the investor interactive platform that as of April 10, 2024, the total number of shareholders of the company was 71,950.
Gelonghui FinanceApr 12 04:21 ET
Opcon TV (300595.SZ): Application for registration of “Hard Breathable Contact Lenses for Corneal Reshaping” was accepted
Gelonghui, April 10 | Opcon TV (300595.SZ) announced that the company recently received the “Notice of Acceptance” (acceptance number: CQZ2400686) from the State Drug Administration, and the company's application for registration of the medical device product “Hard Breathable Contact Lenses for Corneal Reshaping” has been accepted by the State Drug Administration.
Gelonghui FinanceApr 10 06:37 ET
Autek China (SZSE:300595) Could Easily Take On More Debt
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' So it seems
Simply Wall StApr 6 21:44 ET
No Data
No Data